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In the runway model of intracranial self-stimulation (ICSS) experimentation,  the experimental animal 
is timed in running a ﬁxed distance to depress a lever that releases electrical stimulation to an elec-
trode implanted along its medial forebrain bundle.  This ICSS has both a reward and a motivational 
component.  Using the runway method and priming stimulation,  we designed an experimental method 
for directly measuring motivation.  An assessment of pharmacological agents that are known to inﬂu-
ence motivational states was also undertaken.  Using the experimental methods that we created,  we 
observed prominent changes in running speed when animals were exposed to methamphetamine and 
nicotine.  According to these data,  the runway method employing intracranial self-stimulation behav-
ior may be useful for the evaluation of substances that act on motivation.  We review the underlying 
neuropharmacological and anatomical functions associated with our experimental methods.  We hope 
that this technique will be used to scientiﬁcally evaluate the impact of drugs and/or therapeutic inter-
ventions on human motivation.
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n their 2001 report the World Health Organiza-
tion (WHO) described psychiatric disorders as 
being among the major global health issues.  This 
report identiﬁed hypobulia (decreased motivational 
capacity) as a common factor underlying many psychi-
atric disorders [1,  2].  Humans often feel excessive 
stress,  helplessness and hopelessness as an uncom-
fortable emotion or depressive feeling.  When an 
emotion induced by helplessness is ﬁrmly ﬁxed into the 
human mind,  overall motivation may diminish.  Long-
term feelings of helplessness also raise the incidence 
rate of depression [3-6].  Unfortunately,  there are 
few good treatments for alleviating this chronic 
decline in motivation,  and preclinical studies evaluat-
ing drugs that inﬂuence motivation using experimental 
animal models are limited.
　 Intracranial self-stimulation (ICSS) behavior was 
discovered by Olds et al.  [7,  8] and is believed to be 
an eﬀective experimental methodology for understand-
ing reward and motivational systems in both animals 
and humans [9].  According to the “constancy theory” 
[10],  reward and motivational systems exist contigu-
ously in the brain,  and ICSS behavior occurs by both 
systems being activated simultaneously.  However,  
Reid et al.  were successful in developing a runway 
method employing ICSS behavior [11],  which allows 
for discriminative investigation of the separate reward 
and motivational system components underlying the 
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ICSS behavior [12].  By modifying Gallistelʼs runway 
method we have now devised an experimental method-
ology that can be used to evaluate drug eﬃcacy for 
inﬂuencing motivational states.
　 Motivation is an important neural function that 
forms the basis for several critical undertakings in our 
life.  The expression of motivation requires a series of 
aﬀective processes that underlie reward (feelings of 
pleasure).  It is recognized that neuronal signaling in 
the mesolimbic dopamine system in the brain is sig-
niﬁcantly related to the relationship between motiva-
tion and reward.  This review introduces 4 types of 
neuronal processes involved in motivation and reward 
mechanisms.  This review also outlines an evaluation 
of experimental methods [13-15] and describes the 
motivational properties of 2 psychoactive drugs of 
abuse.
Motivation and Reward Processes
　 The process of drive (expectancy of reward).
In the case of food reward,  visceral cues informing 
you of hunger are transferred to the hunger center of 
the lateral hypothalamic area.  Memories of food are 
relayed from memory centers such as the medial tem-
poral lobe,  and a variety of information conditioned by 
food and aﬀective responses associated with such 
information is transferred from the limbic system 
(including the hippocampus and amygdala) to the 
nucleus accumbens.
　 The conversion from drive to action. The 
nucleus accumbens plays the role of an interface con-
verting such visceral and emotional information into 
the action of searching for food.  In order for the 
nucleus accumbens to fulﬁll this function,  orders of 
decision-making from the frontal lobe are required.  
Prior to the search action,  dopamine levels decrease 
once,  and then increase with the actual expression of 
the search action.  Dynamic changes in dopamine nerve 
ﬁring are necessary to convert drive to action.
　 The search action. In the search process,  
information from the nucleus accumbens goes through 
neural connections to the ventral pallidum,  the 
mediodorsal thalamic nucleus,  and the brainstem 
motor area; all of which are related to goal-directed 
motion.  This generates the action of searching for 
food.
　 The reward experience (feelings of pleasure).
This is a process where food is consumed and satisfac-
tion (feelings of subjective pleasure) is experienced.  
In this case,  µ-opiate receptors that mainly exist in the 
ventral tegmental area,  NMDA excitatory amino acid 
(glutamate) receptors,  and D2 dopamine receptors are 
involved.  Dynamic changes of dopamine in the nucleus 
accumbens are necessary to express motivation (will),  
and activation of the endogenous opiate systems or 
dopamine systems in the ventral tegmental area are 
necessary to experience reward (subjective pleasure) 
(Fig.  1).
Experimental Techniques for ICSS Behavior 
and the Runway Method
　 Implantation of electrodes for brain stimula-
tion. Chronic electrodes were implanted at a spe-
ciﬁc brain site along the medial forebrain bundle 
(MFB),  and current from the electrode ﬂowed to that 
brain site,  causing activation of the entire MFB.  Rats 
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Fig. 1　 Process of motivation and reward
could elicit brain stimulation by pressing a lever in a 
Skinner box (“self-stimulation behavior”).  The MFB 
passes through the lateral hypothalamus,  which is 
considered the most active brain reward site [16].
　 The method for implanting the chronic electrode in 
the brain was described previously [17].  Male Wistar 
rats were anesthetized by intraperitoneal injection of 
sodium pentobarbital (Nembutal,  50mg/kg).  Stainless 
steel electrodes consisting of a twisted pair of stain-
less steel wires (tip diameter: 0.2mm),  which were 
insulated except at the top 0.5mm of the tips,  were 
stereotaxically implanted (SR-5; Narishige Scientiﬁc 
Instrument Lab,  Tokyo,  Japan) into the medial fore-
brain bundle (MFB) at the level of the posterior 
hypothalamus (ﬂat skull coordinates: 2.8mm posterior 
to the bregma; 1.8mm lateral to the sagittal suture;  
and 8.5-9.0mm below the skull surface) [18].  After 
the electrodes were inserted into the MFB,  they were 
connected to the pins of a small socket ﬁxed to the 
skull using dental cement,  and 2 screws were driven 
into the skull.  At least 7 days were allowed for the 
rats to recover before beginning training for ICSS 
behavior in a Skinner box.
　 At the end of the experiment,  all subjects were 
given an overdose of chloral hydrate and perfused 
intracardially with saline and formalin (4ｵ).  Coronal 
brain sections were generated and stained with crystal 
violet to determine the placement of electrodes.
　 ICSS training in the Skinner box and runway 
apparatus. One week after surgery the rats were 
trained for ICSS in the Skinner box (30.8cm wide,  
25.4cm length,  and 27.7cm height).  The rats that 
pressed the lever at a stable rate for 3 days in the 
Skinner box (50 presses per minute) were used for the 
runway method.
　 The runway method of Gallistel et al.  was used in 
this experiment [19,  20].  The runway apparatus 
(Neuroscience,  Tokyo,  Japan) was made from 5-mm 
acrylic sections and consisted of a start box (26.5cm 
wide,  26cm long,  and 30cm high),  a controlled start 
door (26.5cm wide,  30cm high) that opened by drop-
ping down,  a runway (18cm wide,  180cm long,  30cm 
high),  and a priming box (30cm wide,  30cm long,  
and 30cm high) (Fig.  2).  A retractable lever was set 
at the end of the runway 7cm above the ﬂoor (the goal 
lever).  Each rat was trained in the runway until its 
running speed stabilized.  Upon reaching the goal end 
and pressing the lever,  they received a reward stimu-
lation of 0.2-msec pulses of 60Hz alternating current.  
The current was set at 50-200µA to produce a maxi-
mal priming stimulation eﬀect (PSE,  the maximal 
diﬀerence between the running speeds on primed ver-
sus unprimed trials).  The stimulation current was 
individually adjusted for each rat.  In a trial,  the rat 
was removed from the runway as soon as it received 
reward stimulation and placed in the priming box that 
stood beside the runway,  where 25 sec later it 
received 10 priming stimulations (1 stimulation per 
second,  the same parameters as the reward).  When 
the priming stimulation ceased,  the rat was trans-
ferred from the priming box to the start box of the 
runway.  Five sec after cessation of the priming stimu-
lation,  the start box door opened.  If the rat ran to the 
goal lever and pushed it,  the rat received reward 
stimulation.  The running time from the opening of the 
door to the pressing of the goal lever was recorded by 
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Fig. 2　 The experimental apparatus used for the runway method of ICSS behavior.  Cited from Acta Med Okayama (2008) 62(4): 227-
233.
microcomputer.
　 Characteristics of priming stimulation in the 
runway method.
1. Correlation of priming stimulation frequency 
and running speed
　 Each rat was trained on the runway until its run-
ning speed was stabilized without priming stimulation.  
Studies of the eﬀect of priming stimulation frequency 
on running speed consisted of 50 consecutive trials,  
with 5 stages of 10 trials each.  The rat received 0,  
1,  3,  5,  and 10 priming stimulations (1 per sec,  the 
same parameters as for the reward) in stages,  and one 
reward stimulation upon pushing the goal lever.  The 
running time from the door opening to the pressing of 
the goal lever was recorded using a microcomputer.
　 The priming stimulation frequency was signiﬁ-
cantly and positively correlated with running speed 
(r＝0.897,  p＜0.05) (Fig.  3).  Running speed also 
increased with the current strength of the priming 
stimulation [20,  21].  These results indicate that in 
the runway method employing ICSS,  priming stimula-
tion enhances running speed to obtain the reward 
stimulation by pressing the goal lever.  In addition,  
Reid et al.  hypothesized that the change in running 
speed with respect to the priming stimulation indicates 
a motivational eﬀect in the runway method [11].  
Thus,  priming stimulation may have enhanced the 
motivation to obtain the reward stimulation.
2. Eﬀect of priming stimulation on running speed 
in the runway method
　 Each rat was trained on the runway until its run-
ning speed was stabilized with 10 trains of priming 
stimulation.  Studies of the eﬀect of priming stimula-
tion on running speed consisted of 45 consecutive tri-
als.  After 10 trials in which a reward stimulation was 
applied,  the rat was subjected to 20 trials in which 
there was no reward stimulation even when the goal 
lever was pressed.  In 15 further trials,  the rat 
received 1 reward stimulation after pushing the goal 
lever.  Under the reward and priming stimulation 
condition,  the rats maintained a steady running speed 
toward the goal lever.  However,  under the condition 
of priming stimulation without reward,  the running 
speed toward the goal lever gradually decreased.  
Thereafter,  returning to the ﬁrst condition of priming 
and reward stimulation,  the running speed toward the 
goal lever rapidly returned to a level similar to the 
original speed under this condition (Fig.  4).
　 The decrease in running speed indicates an extinc-
tion of the eﬀect of the priming stimulations for 
obtaining the reward stimulation.  When the rats were 
subsequently given the reward stimulation again,  the 
running speed toward the goal lever rapidly increased 
and returned to a level similar to that in the previous 
condition of reward and priming stimulation.  Thus,  
the electrical brain stimulation is a reinforcer.  The 
electrical reward and priming stimulations both stimu-
lated the MFB at the same site of the brain.  
Theoretically,  both the electrical reward and priming 
stimulations are potential reinforcers.  However,  the 
observation of the gradual decrease in running speed 
toward the goal lever in the absence of reward stimu-
lation suggests that the electrical reward stimulation,  
and not the priming stimulation,  is the reinforcer in 
this experimental setup.  Instead,  the eﬀects of prim-
ing stimulation are considered to inﬂuence the motiva-
tional eﬀects of obtaining the electrical reward stimu-
lation.
　 Technique for measuring the motivational 
eﬀects of reward drugs on ICSS using the run-
way method. This experimental procedure 
involved 30 trials and consisted of pre-sessions,  base-
line sessions,  and test sessions (Fig.  5).  Each session 
comprised 10 trials.  In the pre-session,  the rat 
received 10 priming stimulations and a reward stimu-
lation for pushing the goal lever.  In the baseline ses-
sion,  the rats received 5 priming stimulations and a 
reward stimulation for pushing the goal lever.  In the 
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Fig. 3　 Correlation of priming stimulation frequency and running 
speed of rats.  Running speed increased with priming stimulation 
frequency.  Each point represents the mean ± S.E.M.  of running 
speed in 10 trials (n＝4).  Cited from Biol Pharm Bull (2008) 
31(4): 541-545.
test session,  after the administration of vehicle or 
drugs,  rats received 5 priming stimulations and a 
reward stimulation for pushing the goal lever.  Vehicle 
and drugs were administered before the baseline or 
test session.  The motivational eﬀect of the drugs was 
determined as the ratio of the baseline running time to 
the test-session running time.  When the running time 
for the test session was signiﬁcantly lower than the 
running time of the baseline session,  it was deter-
mined that the motivational eﬀect of the tested drug 
was positive.
Assessment of the Motivational Eﬀects of 
Methamphetamine
　 We ﬁrst measured the motivational eﬀects of meth-
amphetamine,  a psychostimulant drug that is well 
known to enhance motivation clinically.  At 1 and 
3mg/kg,  methamphetamine produced an increase in 
running speed (F (3,  20)＝16.257,  p＜0.01),  sug-
gesting that methamphetamine facilitates priming 
stimulation with respect to ICSS behavior in the 
runway test (Fig.  6).  Methamphetamine-induced 
hyperactivity is insuﬃcient to explain the observed 
enhancement of target-oriented behavior.  Motivational 
and rewarding eﬀects are indispensable for completion 
of the target-oriented behavior,  and such complex 
behavior is not simply regulated by locomotor activity.  
In the end,  the inﬂuence of methamphetamine-induced 
hyperactivity on goal-directed behavior should be much 
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Fig. 4　 Eﬀect of reinforcing stimulation on running speed in the runway test.  Experiments consisted of 45 consecutive trials.  Contingent 
rewarding (reinforcing) stimulation was not available during trials 11-30,  but was available in trials 31-45.  [Remark 3] The assigned val-
ues are the mean ± S.E.M.  for 4 rats.  Prim.,  priming stimulation; Rew.,  reward stimulation.  Cited from Biol Pharm Bull (2008) 
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Fig. 5　 Experimental design for the measurement of motivation 
and running speed.  (A) Each session consisted of 10 trials.  The 
value assigned for each rat was the mean value of 10 trials in each 
session.  When the value for the test session was signiﬁcantly 
higher than the value for the baseline session,  the test drug was 
considered to have a motivational eﬀect.  (B) Running speed in the 
pre-session,  baseline session,  and test session.  Saline was 
administered in the baseline and test sessions.  Each column repre-
sents the mean ± S.E.M.  of 6 rats.  Data were analyzed by one-
way ANOVA followed by the Sheﬀé test. ＊p＜0.05,  signiﬁcantly 
diﬀerent from baseline session.  Prim.,  priming stimulation; Rew.,  
reward stimulation.  Cited from Biol Pharm Bull (2008) 31(4): 541-
545.
less than its motivational eﬀect.
　 Psychostimulants such as methamphetamine aﬀect 
the mesoaccumbens dopaminergic system [22,  23].  
This system is closely connected with the motivational 
nervous system [24-27],  and might be one of the 
neural substrates inﬂuenced by methamphetamine.  In 
the current study,  the electrodes for ICSS were 
implanted in the MFB.  At the level of the posterior 
hypothalamus,  the MFB intersects with the mesoac-
cumbens dopaminergic pathway.  Thus,  it is conceiv-
able that methamphetamine activates the mesoaccum-
bens dopaminergic system and facilitates priming 
stimulation due to stimulation of the MFB.
　 It was also demonstrated that running speed was 
signiﬁcantly enhanced with a moderate dose of nico-
tine (0.2mg/kg) [F (3,  20)＝4.756,  p＜0.05].  With 
both a smaller dose (0.05mg/kg) and a higher dose 
(0.5mg/kg),  the running speed remained unchanged,  
similar to the eﬀects of saline.  The eﬀect of nicotine 
on ICSS behavior in the runway method thus dis-
played an inverted U-shaped dose-response curve 
(Fig.  7).  This inverted U-shaped dose response is 
consistent with results of other nicotine self-adminis-
tration studies,  where an intravenous injection dose of 
0.03mg/kg has been shown to reliably support operant 
responding in animals [28-35].  Furthermore,  modiﬁ-
cations of the nicotine U-shaped dose-response curve 
in forced swimming tests have been used as a screen-
ing method for antidepressants.  Nicotine,  at a subcu-
taneous injection dose of 0.2mg/kg,  has been shown to 
signiﬁcantly decrease the duration of immobility in 
forced swimming tests after examining an experimen-
tal dose range of 0.01-1.0mg/kg [35].  In addition,  
subcutaneous injection of nicotine at a dose of 0.2mg/
kg signiﬁcantly inhibited the eﬀect of naloxone-
induced place aversion [36-38].  These ﬁndings indi-
cated that the subcutaneous injection dose of 0.2mg/
kg nicotine was suitable for alleviating both depres-
sion-like behavior and aversive motivational states.  
These results may explain why subcutaneous injection 
of 0.2mg/kg nicotine was the optimal dose for enhanc-
ing running speed and motivation.
General Discussion of Motivational Eﬀects 
Induced by the Opportunity for Intracranial 
Self-Stimulation
　 “Motivation” is a process that moves behavior con-
tinuously along one direction towards a goal,  and can 
be conceptualized as a series of steps relating to that 
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Fig. 7　 The motivational eﬀect of nicotine on the runway method 
using priming stimulation.  Each column shows the ratio of baseline 
running speed to test session running speed.  Saline and nicotine 
(0.05,  0.2,  0.5mg/kg) were administered by subcutaneous injec-
tion (s.c.) 30min prior to the measurement.  Data represent the 
mean ± S.E.M.  of 6 rats.  Data were analyzed by one-way ANOVA 
followed by the Scheﬀé test.  Change in running speed following 
administration of 0.2mg/kg nicotine was signiﬁcantly diﬀerent from 
that observed after saline injection.  ＊p＜0.05.  Cited from Acta Med 
Okayama (2008) 62(4): 227-233.
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Fig. 6　 Motivational eﬀect of methamphetamine on ICSS behav-
ior in the runway test using priming stimulation.  Each column 
shows the percentage by which running speed in the test session 
diﬀered from that in the baseline session.  Saline (0.9% sodium 
chloride) and methamphetamine (0.2,  1,  and 3mg/kg) were admin-
istered by i.p.  injection 30min before the measurement. Each result 
represents the mean ± S.E.M.  of 6 rats.  Data were analyzed by 
one-way ANOVA followed by the Sheﬀé test. ＊p＜0.05, signiﬁ-
cantly diﬀerent from saline.  Cited from Biol Pharm Bull (2008) 
31(4): 541-545.
process.  Thus,  motivation can be deﬁned as either a 
factor that regulates goal-oriented behavior or the 
entire interaction of a variety of factors involved in 
such an aim.
　 Motivation in psychology is divided into physiolog-
ical motivation and other motivations.  Physiological 
motivation relates to drinking behavior,  eating behav-
ior,  thermoregulatory behavior,  sexual behavior,  and 
emotional behavior.  On the other hand,  other motiva-
tions include intrinsic motivations,  such as personal 
interests and curiosity,  and social motivation,  which 
relates to interpersonal behavior.  For humans,  it is 
mainly dysfunctions in intrinsic and social motivations 
that can lead to social problems.  Thus,  animal models 
targeting intrinsic motivation,  not physiological moti-
vation,  may be more suitable to evaluate medicines 
that act on human motivation.  We used ICSS behavior 
in animals to evaluate the eﬃcacy of medicines that act 
on motivation since this animal model is thought to 
have high face and predictive validity in modeling 
psychiatric disorders of intrinsic motivation.
　 Traditional operant intracranial self-stimulation 
(ICSS) behavior is comprised of both a reward and a 
motivational eﬀect.  Priming stimulation is known to 
promote the motivational eﬀects of ICSS behavior 
[39].  Using the runway method and priming stimula-
tion,  the reward and motivational eﬀects of ICSS 
behavior can be distinguished [39].  The operant 
runway procedure has been successfully used to study 
the motivating properties of a wide variety of rein-
forcers,  including food [40],  water [41],  and sex 
[42],  as well as intravenous heroin [43,  44],  ampheta-
mine [45],  nicotine [46],  and cocaine [47].  These 
reports indicate that the operant running speed 
reﬂects the animalʼs motivation [43-47].
　 Using a runway method of experimentation and the 
opportunity for ICSS as reward,  we showed that run-
ning speed substantially increased as the number of 
priming stimulations increased.  We believe that the 
priming stimulation given before the animals were put 
in the start box increased the drive of seeking the goal 
lever,  which in turn increased running speed.  
Waraczynski et al.  reported similar results [48],  and 
also reported that under priming stimulation condi-
tions the running speed also increased with increases 
in simulation frequency (without changing the current 
of the reward stimulation).  Our study results comple-
ment the results of Waraczynski et al.  in that motiva-
tion was increased when we changed the number of 
stimulations; they changed the frequency.  The impact 
of priming stimulations in the runway method can be 
interpreted as behavioral changes resulting from 
activation of neuronal substrates in the brain subserv-
ing motivation.  The experimental results shown in 
Fig.  3 strongly support this interpretation.  Our 
results demonstrate that the priming stimulation can-
not act as a reinforcing stimulation.  If the priming 
stimulation was reinforcing,  the rats would have con-
tinued to run at the same pace even under extinction 
conditions with respect to the runway-lever pairing.  
Considering the behavioral characteristics of rats,  
they might eventually alter their behavior by recogniz-
ing the priming stimulation that is given 10 times as a 
new rewarding stimulation,  more so than the stimula-
tion of a goal lever that is only received once.  Rats 
that are not rewarded by a goal lever might gradually 
start running to obtain stimulation that is given in the 
priming box.  In this case,  the priming stimulation can 
become reinforcing.  In our experiment,  when only 
priming stimulation was given,  the running speed 
toward the goal lever decreased in each trial.  When 
the rats were again allowed to run while the reinforc-
ing stimulation by the goal lever was available,  the 
running speed gradually increased and by the 10th 
trial the running speed returned to that observed dur-
ing the pre-session.  Instead of a reinforcer,  the prim-
ing stimulation in the runway method can best be 
interpreted as a stimulation that inactivates the drive 
mechanism that compels the rats to run toward a goal 
lever to obtain rewards.  Medicines that impact the 
priming stimulation eﬀect in the runway method may 
represent drugs that inﬂuence the neural mechanisms 
of motivation.
　 Using the experimental methods that we created,  
we observed prominent changes in running speed after 
exposure to methamphetamine and nicotine,  corre-
sponding to their well known eﬀects on motivation.  As 
these substances serve as positive controls,  our 
results indicate that the runway method of ICSS 
behavior may be used to evaluate drugs that act on 
motivation.  In addition,  it is of note that certain 
anxiolytic agents [49],  anti-depression drugs [50],  
and drugs to treat Parkinsonʼs disease also modify the 
eﬀects of priming stimulation in this method.  We hope 
the experimental method that we created will be used 
in the future to scientiﬁcally evaluate the impact of 
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drugs and therapeutic medicines on human motivation.
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